Overview
Richter BioLogics is a Germany-based CDMO specializing in microbial production of biologics from bacteria and yeasts, including recombinant proteins, peptides, VHH/nanobodies, plasmid DNA, and bacterial vaccines. It offers cGMP-compliant services from cell line and process development to commercial manufacturing across fermenter scales of 10L to 1,500L in three facilities. With over 35 years of experience, the company supports E. coli, P. pastoris, cell-free systems, and additional strains.
Frequently asked questions
- What production systems and scales does Richter BioLogics support?
- Specializes in E. coli, P. pastoris, and cell-free (CFPS) systems, with support for additional microbial strains. Offers fermentation capacities from 10L to 1,500L across three facilities, including 2 x 1,500L and 2 x 300L.
- What types of biologics does Richter BioLogics manufacture?
- Produces recombinant proteins and peptides, antibody-like scaffolds (VHH/nanobodies, Fab fragments), plasmid DNA (pDNA) via proprietary RB-pART process, and bacterial vaccines.
- What regulatory standards and locations apply to Richter BioLogics?
- Operates cGMP-compliant facilities in Germany (Hamburg and Bovenau), with additional sites in Hungary. Focuses on microbial expression for biopharmaceuticals meeting stringent industry standards.